Tessera Therapeutics is a biotechnology company developing programmable genetic medicines using its Gene Writing technology, which is based on mobile genetic elements to insert, replace, or modify DNA in cells. It aims to develop treatments for genetic diseases and other serious conditions, serving patients who need durable genetic therapies.
Subscribe to see Tessera Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tessera Therapeutics is a biotech company headquartered in United States. Xcout tracks 17 named people at Tessera Therapeutics, including Joseph Romanelli (President and Chief Executive Officer, Board Director). Xcout recorded 5 job postings from Tessera Therapeutics in the last 90 days.
11 more named people on record for Tessera Therapeutics, with roles, board committees and tenure — see the full roster →
Xcout recorded 5 job postings from Tessera Therapeutics in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Tessera Therapeutics's hiring signals →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.